Rationale Some of the behavioral consequences of deficits in N-methyl-d-aspartate (NMDA)
glutamate receptor function are thought to arise from the disinhibition of cortical …

Rationale N-methyl-d-Aspartate receptor (NMDAR) antagonists such as ketamine induce
cognitive symptoms in man similar to those of schizophrenia and therefore might be useful …

Rationale N-methyl-d-aspartate (NMDA) glutamate receptor antagonists have been reported
to induce schizophrenia-like symptoms in humans, including memory impairments. Although …

A rapidly growing body of preclinical data has implicated the glutamatergic N-methyl-d-
aspartate (NMDA) receptor in memory and other cognitive processes. There is …

N-methyl-D-aspartate (NMDA) glutamate receptor antagonists are reported to induce
schizophrenia-like symptoms in humans, including cognitive impairments. Shortcomings of …

Abstract N-methyl-D-aspartate (NMDA) receptor antagonists have been demonstrated to
induce schizophrenia-like symptoms and cognitive impairment in humans. The NMDA …

Hypofunction of the N-methyl-D-aspartate receptor (NMDAR) may be involved in the
pathophysiology of schizophrenia. NMDAR antagonists like ketamine induce schizophrenia …

Background The cognitive, behavioral, and mood effects ofN-methyl-D-aspartate (NMDA)
receptor antagonists, such as phencyclidine and ketamine, have been used to study the …

Pharmacological manipulation of N-methyl-D-aspartate (NMDA) receptors may be critical for
the treatment of many neurological and psychiatric disorders. Metabotropic glutamate …

Glutamate-induced neurotoxicity plays an important role in neurological and psychiatric
diseases. Thus, much attention has been given to the potential neuroprotective role of …